Earl Martin Douglas, General Counsel at Biomimetic Therapeutics, holds 0.00 shares in Biomimetic Therapeutics (Ticker: BMTI), holds 477.63K shares in Allogene Therapeutics (Ticker: ALLO). Most recently, Earl Martin Douglas ― shares of Biomimetic Therapeutics on ― for an estimated value of ―.